Farther Finance Advisors’s Evogene EVGN Stock Holding History

Farther Finance Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$1	–	5803
2025 Q4	$1	Buy	+1	New	+$1	﹤0.01%	5447

Other funds holding EVGN

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Farther Finance Advisors's EVGN Position: Q1 2026 in Review

Farther Finance Advisors sold out of Evogene (EVGN) in Q1 2026, closing a stake of 1 share — an estimated $1 sold.

Farther Finance Advisors first reported a position in EVGN in Q4 2025 and held it in 1 quarter. The position peaked at $1 in Q4 2025. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

Farther Finance Advisors reported no remaining Evogene position as of Q1 2026 after selling out during the quarter.
Farther Finance Advisors sold 1 Evogene share in Q1 2026, an estimated $1.
Farther Finance Advisors first reported a position in Evogene in Q4 2025 and held it in 1 quarter.
Farther Finance Advisors's Evogene position peaked at $1 in Q4 2025.
15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.